As shown in Figure3A, we treated K562 cells, which are a Ph+ and Tp53‐deleted CML cell line, with different concentrations of PMIBcr/Abl‐R6 and Bcr/Abl‐R6. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.